For more than 50 years, speculation has swirled about the tremendous potential of Ga-68 PET imaging to transform molecular imaging. The rapidly increasing number of publications reporting the results of Ga-68 PET imaging studies are evidence that many are working in this direction. 

Delayed brain injury resulting from aggressive radiation treatment can be differentiated from recurrent brain tumors using F-18 FDOPA PET imaging, according to a study published Oct. 28 in the Journal of Nuclear Medicine.

New research brings 11 new genes into focus as potential links to Alzheimer's and other neurodegenerative diseases including Parkinson's and multiple sclerosis, all associated with the build-up of protein plaques in the brain. The data was made available as a result of the international Genomics of Alzheimer's Project (IGAP), according to an Oct. 28 report by The Huffington Post.

The global PET market is set to grow an estimated 3.74 percent from 2012-2016, according to a report published this month by the market research firm Infiniti Research Limited.

Lantheus Medical Imaging has announced preliminary phase III clinical trial results for F-18 flurpiridaz as a diagnostic PET agent for myocardial perfusion imaging indicating high sensitivity but potentially lagging specificity for the detection of CAD.

The FDA has added regadenoson, an adenosine myocardial perfusion agent used during cardiac stress tests, to its most recent watch list for potentially life-threatening side effects.

Over the past five years, medical imaging enterprises have learned the hard way that adaptability and flexibility are prized qualities required for survival. They have weathered reimbursement cuts, increased scrutiny and the general feeling that they are ceding control of their businesses to outside agencies with agendas and motivations far different than theirs. What was once a smooth operation providing key medical information is now a daily battle to maintain viability.

Imaging the inflammatory response with PET could provide more information about traumatic brain injury (TBI) than conventional CT and MRI methods, according to research presented during the Military Health System Research Symposium held in Ft. Lauderdale, Fla., Aug. 12.